Introduction
Kidney Transplant Rejection - Overview
Kidney Transplant Rejection - Therapeutics Development
Kidney Transplant Rejection - Therapeutics Assessment
Kidney Transplant Rejection - Companies Involved in Therapeutics Development
Kidney Transplant Rejection - Drug Profiles
Kidney Transplant Rejection - Dormant Projects
Kidney Transplant Rejection - Discontinued Products
Kidney Transplant Rejection - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Kidney Transplant Rejection, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Kidney Transplant Rejection - Pipeline by Alphamab Oncology, 2021
Kidney Transplant Rejection - Pipeline by Amgen Inc, 2021
Kidney Transplant Rejection - Pipeline by Amyndas Pharmaceuticals LLC, 2021
Kidney Transplant Rejection - Pipeline by Astellas Pharma Inc, 2021
Kidney Transplant Rejection - Pipeline by Bristol Myers Squibb Co, 2021
Kidney Transplant Rejection - Pipeline by Cynata Therapeutics Ltd, 2021
Kidney Transplant Rejection - Pipeline by Eledon Pharmaceuticals Inc, 2021
Kidney Transplant Rejection - Pipeline by Enceladus Pharmaceuticals BV, 2021
Kidney Transplant Rejection - Pipeline by Genzyme Corp, 2021
Kidney Transplant Rejection - Pipeline by Hansa Biopharma AB, 2021
Kidney Transplant Rejection - Pipeline by Helocyte Biosciences Inc, 2021
Kidney Transplant Rejection - Pipeline by Hillhurst Biopharmaceuticals Inc, 2021
Kidney Transplant Rejection - Pipeline by Horizon Therapeutics Plc, 2021
Kidney Transplant Rejection - Pipeline by Idogen AB, 2021
Kidney Transplant Rejection - Pipeline by ITB-Med AB, 2021
Kidney Transplant Rejection - Pipeline by JN Biosciences LLC, 2021
Kidney Transplant Rejection - Pipeline by Junten Bio Co Ltd, 2021
Kidney Transplant Rejection - Pipeline by Kiniksa Pharmaceuticals Ltd, 2021
Kidney Transplant Rejection - Pipeline by Kronos Bio Inc, 2021
Kidney Transplant Rejection - Pipeline by Lyndra Therapeutics Inc., 2021
Kidney Transplant Rejection - Pipeline by Mabtech Ltd, 2021
Kidney Transplant Rejection - Pipeline by Medeor Therapeutics Inc, 2021
Kidney Transplant Rejection - Pipeline by MyeloRx LLC, 2021
Kidney Transplant Rejection - Pipeline by Nekonal Sarl, 2021
Kidney Transplant Rejection - Pipeline by NextCell Pharma AB, 2021
Kidney Transplant Rejection - Pipeline by Novartis AG, 2021
Kidney Transplant Rejection - Pipeline by OSE Immunotherapeutics, 2021
Kidney Transplant Rejection - Pipeline by Paranta Biosciences Ltd, 2021
Kidney Transplant Rejection - Pipeline by Pharmapraxis, 2021
Kidney Transplant Rejection - Pipeline by Rigel Pharmaceuticals Inc, 2021
Kidney Transplant Rejection - Pipeline by Sangamo Therapeutics Inc, 2021
Kidney Transplant Rejection - Pipeline by Talaris Therapeutics Inc, 2021
Kidney Transplant Rejection - Pipeline by TolerogenixX GmbH, 2021
Kidney Transplant Rejection - Pipeline by Tonix Pharmaceuticals Holding Corp, 2021
Kidney Transplant Rejection - Pipeline by TRACT Therapeutics Inc, 2021
Kidney Transplant Rejection - Pipeline by Veloxis Pharmaceuticals AS, 2021
Kidney Transplant Rejection - Pipeline by Xencor Inc, 2021
Kidney Transplant Rejection - Dormant Projects, 2021
Kidney Transplant Rejection - Dormant Projects, 2021 (Contd..1)
Kidney Transplant Rejection - Dormant Projects, 2021 (Contd..2)
Kidney Transplant Rejection - Discontinued Products, 2021

List of Figures
Number of Products under Development for Kidney Transplant Rejection, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

Companies Mentioned
• Alphamab Oncology
• Amgen Inc
• Amyndas Pharmaceuticals LLC
• Astellas Pharma Inc
• Bristol Myers Squibb Co
• Cynata Therapeutics Ltd
• Eledon Pharmaceuticals Inc
• Enceladus Pharmaceuticals BV
• Genzyme Corp
• Hansa Biopharma AB
• Helocyte Biosciences Inc
• Hillhurst Biopharmaceuticals Inc
• Horizon Therapeutics Plc
• Idogen AB
• ITB-Med AB
• JN Biosciences LLC
• Junten Bio Co Ltd
• Kiniksa Pharmaceuticals Ltd
• Kronos Bio Inc
• Lyndra Therapeutics Inc.
• Mabtech Ltd
• Medeor Therapeutics Inc
• MyeloRx LLC
• Nekonal Sarl
• NextCell Pharma AB
• Novartis AG
• OSE Immunotherapeutics
• Paranta Biosciences Ltd
• Pharmapraxis
• Rigel Pharmaceuticals Inc
• Sangamo Therapeutics Inc
• Talaris Therapeutics Inc
• TolerogenixX GmbH
• Tonix Pharmaceuticals Holding Corp
• TRACT Therapeutics Inc
• Veloxis Pharmaceuticals AS
• Xencor Inc